As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

The federal government gave the greenlight in January for Vermont to use funds from Medicaid to cover the cost of ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

The US Medicare agency dropped its appeal of a lawsuit brought by UnitedHealth Group Inc. challenging the program’s ...

UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...

Trump dismissed the order as part of what he called Biden’s “unpopular, inflationary, illegal, and radical practices.” ...

The Trump Administration and 119th Congress will likely be targeting trillions of dollars in savings in the year ahead. Healthcare makes up ...

CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...

(HealthDay News) — Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news ...

President Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Menopause is a natural phase of life that brings unique health challenges, from hot flashes and sleep disturbances to ...